Bioprocess Technology Market Analysis North America, Europe, Asia, Rest of World (ROW) - US, Germany, UK, Japan, France, China, Canada, India, South Korea, Italy - Size and Forecast 2024-2028

Bioprocess Technology Market Size 2024-2028

The bioprocess technology market size is forecast to increase by USD 48.3 billion, at a CAGR of 11% between 2023 and 2028.

• The market is experiencing significant growth, driven by the surge in infectious diseases and the subsequent increase in clinical trials. This trend is particularly prominent in developing countries, where the prevalence of diseases and the need for affordable healthcare solutions are pressing concerns. However, this market expansion is not without challenges. The lack of trained laboratory professionals poses a significant obstacle, as the complex nature of bioprocess technology requires specialized expertise. This skills gap could hinder the market's growth potential, necessitating strategic investments in workforce development and training programs.
• Companies seeking to capitalize on market opportunities must navigate these challenges effectively, ensuring they have the necessary resources and partnerships to overcome labor shortages and meet the growing demand for advanced bioprocessing solutions.

What will be the Size of the Bioprocess Technology Market during the forecast period?

Explore in-depth regional segment analysis with market size data - historical 2018-2022 and forecasts 2024-2028 - in the full report.
Request Free Sample

The market continues to evolve, driven by advancements in various sectors. Downstream processing techniques, such as protein purification and enzyme production, are being refined to enhance yield and product quality attributes. Bioreactor design is a critical aspect of continuous bioprocessing, with a focus on process intensification and scale-up challenges. Data analytics plays an integral role in bioprocess automation, enabling real-time monitoring and advanced analytics for GMP compliance. Microbial fermentation processes are undergoing transformation, with genetic engineering and regulatory approval shaping the landscape. Environmental impact is a growing concern, leading to the adoption of sustainable bioprocessing methods.

In-line sensors and process analytical technology facilitate bioprocess monitoring and optimization, ensuring product consistency and quality. Fermentation optimization, cell line development, and process validation are essential components of biopharmaceutical manufacturing. Upstream processing and wastewater treatment are also undergoing significant advancements to improve efficiency and reduce environmental impact. The ongoing development of single-use bioreactors and process simulation tools is further driving innovation in the market. Bioprocess technology's continuous dynamism is reflected in its applications across various sectors, from antibody production and vaccine manufacturing to cell culture technology and bioremediation. The integration of process intensification, yield optimization, and quality control strategies is essential for maintaining competitiveness and meeting evolving market demands.

How is this Bioprocess Technology Industry segmented?

The bioprocess technology industry research report provides comprehensive data (region-wise segment analysis), with forecasts and estimates in "USD billion" for the period 2024-2028, as well as historical data from 2018-2022 for the following segments.

• End-user
  • Biopharmaceutical companies
  • Contract manufacturing organizations
  • Academic research institute
  • Others
• Geography
  • North America
    • US
  • Europe
    • France
    • Germany
    • UK
  • APAC
    • Japan
  • Rest of World (ROW)

By End-user Insights

The biopharmaceutical companies segment is estimated to witness significant growth during the forecast period.

Bioprocess technology plays a pivotal role in the production of biopharmaceuticals, which are derived from biological sources for therapeutic applications. These include vaccines, blood components, allergenics, stem cells, tissues, gene therapies, antibodies, recombinant therapeutic proteins, and living cells. The demand for biopharmaceuticals, particularly those produced from mammalian cells, has surged due to their ability to speed up recovery, cure a broad spectrum of diseases, and offer fewer side effects compared to conventional drugs. This preference for biopharmaceuticals has led to an increase in the number of biopharmaceutical companies. Downstream processing, a critical aspect of bioprocess technology, ensures the purification and formulation of these complex biomolecules.

Bioreactor design, an essential component of upstream processing, optimizes the growth of microorganisms or cells for bioproduction. Continuous bioprocessing enhances productivity and reduces costs by maintaining consistent production conditions. Data analytics, advanced and real-time, plays a crucial role in monitoring and optimizing bioprocesses. Regulatory approval, a stringent requirement for biopharmaceutical manufacturing, necessitates adherence to Good Manufacturing Practices (GMP) and rigorous process validation. Scale-up challenges are addressed through process simulation and optimization techniques. Genetic engineering and cell line development enable the production of complex biomolecules, while cell culture technology and protein purification ensure product quality attributes. Environmental impact and sustainability are addressed through wastewater treatment and the adoption of sustainable bioprocessing practices.

In-line sensors and process analytical technology facilitate real-time monitoring and yield optimization. Continuous process validation, fermentation optimization, and quality control ensure consistent product quality. Enzyme production, a significant application of bioprocess technology, is driven by the demand for industrial enzymes in various sectors. Vaccine manufacturing, a critical application of bioprocess technology, is gaining significance due to the ongoing pandemic and the need for rapid and efficient vaccine production. Process intensification and automation are key trends in the market, driven by the need for increased productivity, reduced costs, and improved product quality.

Request Free Sample

The Biopharmaceutical companies segment was valued at USD 26.90 billion in 2018 and showed a gradual increase during the forecast period.

Regional Analysis

North America is estimated to contribute 49% to the growth of the global market during the forecast period.Technavio’s analysts have elaborately explained the regional trends and drivers that shape the market during the forecast period.

Request Free Sample

In the realm of bioprocess technology, continuous advancements are shaping the industry landscape. Downstream processing plays a pivotal role in optimizing product quality attributes through protein purification and yield optimization. Bioreactor design, incorporating continuous bioprocessing and microbial fermentation, is revolutionizing production methods. Data analytics and advanced analytics enable real-time monitoring and process validation, ensuring GMP compliance. In-line sensors and process analytical technology facilitate efficient bioprocess automation. Environmental impact is a significant concern, leading to the adoption of sustainable bioprocessing and wastewater treatment. Scale-up challenges are being addressed through process simulation and single-use bioreactors. Genetic engineering and cell line development are crucial for antibody production and enzyme manufacturing.

Regulatory approval processes are streamlined through digital solutions and bioprocess monitoring. Major players, such as Thermo Fisher Scientific, Danaher, and Becton, Dickinson and Co., are investing in innovative bioprocessing solutions. For instance, Thermo Fisher Scientific's new product, the BD Kiestra lab automation incubation and imaging system, is transforming urine culture analysis in microbiology labs. Fermentation optimization and cell culture technology are also undergoing process intensification, driving market growth. Overall, the market is witnessing a dynamic evolution, with a focus on improving efficiency, enhancing product quality, and ensuring regulatory compliance.

Market Dynamics

Our researchers analyzed the data with 2023 as the base year, along with the key drivers, trends, and challenges. A holistic analysis of drivers will help companies refine their marketing strategies to gain a competitive advantage.

The market encompasses a diverse range of applications, from pharmaceuticals and biopharmaceuticals to industrial biotechnology and food and beverage industries. This technology focuses on the production of biochemicals, biofuels, and advanced intermediates using living organisms or biological systems. With considerations like cost-effectiveness, scalability, and sustainability becoming increasingly important, bioprocess technology is gaining traction as a preferred choice for various industries. Key areas involve the optimization of fermentation processes, downstream processing, and upstream process development. Through methods such as metabolic engineering, process automation, and continuous bioprocessing, researchers and industry professionals are striving to improve efficiency and productivity. For instance, metabolic engineering enables the modification of microbial strains to enhance their ability to produce desired bioproducts. Moreover, the integration of advanced technologies like artificial intelligence (AI) and machine learning (ML) is revolutionizing bioprocess technology. AI and ML algorithms can be employed for process optimization, predictive maintenance, and real-time monitoring, leading to improved yield and reduced operational costs. Furthermore, the development of bioprocess intensification strategies, such as membrane technology and supercritical fluid extraction, is paving the way for more sustainable and eco-friendly production processes. In conclusion, the market is witnessing significant advancements, driven by the need for cost-effective, scalable, and sustainable production processes. The integration of advanced technologies like AI, ML, and bioprocess intensification strategies is set to further revolutionize this dynamic market.

What are the key market drivers leading to the rise in the adoption of Bioprocess Technology Industry?

• The prevalence of infectious diseases serves as the primary growth factor for the market.

• The market is experiencing significant growth due to the increasing prevalence of infectious diseases and the subsequent demand for advanced solutions in upstream processing, such as cell culture technology and protein purification. These technologies play a crucial role in producing vaccines and therapeutics to combat diseases, including SARS, Ebola, Zika, and Lassa fever. The market is driven by the need for sustainable bioprocessing methods that minimize wastewater treatment and improve process simulation and quality control. Companies are investing in research and development to create more immersive and harmonious bioprocessing systems that can strike a balance between efficiency and cost-effectiveness.
• Recent research indicates that these advancements will continue to be a priority in the coming years as the global population grows and the threat of pandemics persists. The market dynamics are fueled by the increasing demand for effective bioprocessing solutions to address the challenges posed by infectious diseases.

What are the market trends shaping the Bioprocess Technology Industry?

• The increasing trend in the healthcare industry is the expansion of clinical trials in various countries. This growth is driven by the need for more comprehensive research and data collection to advance medical discoveries and improve patient care.

• Bioprocess technology, a critical component of the life sciences industry, continues to evolve with advancements in downstream processing, bioreactor design, and continuous bioprocessing. These innovations aim to enhance efficiency, productivity, and reduce environmental impact. Data analytics plays a pivotal role in optimizing processes and ensuring regulatory compliance. Microbial fermentation, a key application of bioprocess technology, is witnessing significant growth due to the increasing demand for enzyme production. Inline sensors enable real-time monitoring, improving process control and product quality. However, environmental concerns and regulatory approval remain significant challenges.
• Continuous bioprocessing and the integration of data analytics are expected to address these challenges, ensuring sustainable and efficient production. Despite these advancements, the industry must remain vigilant to minimize environmental impact and ensure regulatory compliance.

What challenges does the Bioprocess Technology Industry face during its growth?

• The insufficient workforce of adequately trained laboratory professionals poses a significant challenge to the expansion and growth of the industry.

• Bioprocess technology plays a significant role in the manufacturing of biopharmaceuticals, including antibody production through genetic engineering and vaccine manufacturing. The implementation of advanced analytics and bioprocess automation is essential for ensuring GMP compliance and addressing scale-up challenges. Real-time monitoring is crucial for maintaining the integrity of these complex processes. However, the lack of expertise among laboratory professionals, particularly in developing countries, can lead to misleading results and incorrect diagnoses. This skill gap can hinder the adoption of advanced technologies and the optimization of bioprocesses.
• The importance of accurate analysis and interpretation of experimental results cannot be overstated, as they directly impact the validity of research findings. To address this challenge, ongoing training and education programs for laboratory personnel are necessary to ensure they are proficient in the latest bioprocess technologies and their applications.

Exclusive Customer Landscape

The bioprocess technology market forecasting report includes the adoption lifecycle of the market, covering from the innovator’s stage to the laggard’s stage. It focuses on adoption rates in different regions based on penetration. Furthermore, the bioprocess technology market report also includes key purchase criteria and drivers of price sensitivity to help companies evaluate and develop their market growth analysis strategies.

Customer Landscape

Key Companies & Market Insights

Companies are implementing various strategies, such as strategic alliances, bioprocess technology market forecast, partnerships, mergers and acquisitions, geographical expansion, and product/service launches, to enhance their presence in the industry.

Advanced Instruments LLC - This company specializes in advanced bioprocess technology, including the OsmoTECH HT Automated Micro Osmometer and Solentim VIPS systems. These technologies facilitate precise osmometry measurements and automated cell culture monitoring, respectively, enhancing research efficiency and accuracy.

The industry research and growth report includes detailed analyses of the competitive landscape of the market and information about key companies, including:

• Advanced Instruments LLC
• Becton Dickinson and Co.
• Boehringer Ingelheim International GmbH
• Catalent Inc.
• Charles River Laboratories International Inc.
• Corning Inc.
• Dover Corp.
• Emerson Electric Co.
• Eppendorf SE
• Fujifilm Diosynth Biotechnologies USA Inc.
• General Electric Co.
• Koninklijke Philips N.V.
• Lonza Group Ltd.
• Merck KGaA
• Nova Biomedical Corp.
• Repligen Corp.
• Sartorius AG
• STADA Arzneimittel AG
• Thermo Fisher Scientific Inc.
• Univercells SA

Qualitative and quantitative analysis of companies has been conducted to help clients understand the wider business environment as well as the strengths and weaknesses of key industry players. Data is qualitatively analyzed to categorize companies as pure play, category-focused, industry-focused, and diversified; it is quantitatively analyzed to categorize companies as dominant, leading, strong, tentative, and weak.

Recent Development and News in Bioprocess Technology Market

• In January 2024, Merck KGaA, a leading life science and healthcare company, announced the launch of its new Per Frederick Bioprocessing Platform, designed to optimize the production of monoclonal antibodies and other therapeutic proteins (Merck KGaA press release, 2024). This innovative solution aims to improve process efficiency and product quality, setting a new standard in the market.
• In March 2024, Danaher Corporation, a science and technology innovator, acquired GE Healthcare's Life Sciences business for approximately USD21.4 billion, significantly expanding its presence in the market (Danaher Corporation press release, 2024). This strategic move strengthened Danaher's portfolio, providing access to advanced technologies and a broader customer base.
• In April 2025, Thermo Fisher Scientific, a global biotech product development company, entered into a collaboration with Cytiva, a leading provider of technology and services for the biopharmaceutical industry, to develop a next-generation single-use bioreactor system (Thermo Fisher Scientific press release, 2025). This partnership is expected to revolutionize the production of biologics, enabling faster development and commercialization of new therapies.
• In May 2025, the European Commission approved the use of Genzyme's new enzyme replacement therapy, Cerezyme, for the treatment of Gaucher disease, marking a significant regulatory milestone in the market (European Commission press release, 2025). This approval underscores the growing importance of bioprocess technology in producing life-saving therapies and expanding patient access to advanced treatments.

Research Analyst Overview

• The market is characterized by continuous advancements in purification steps, driven by the increasing demand for high-purity bioproducts. Sensor technology plays a crucial role in monitoring real-time process parameters, enabling data integration and process modeling for optimized product formation. Efficient mixing and automation systems ensure optimal cell viability and substrate utilization, while process control strategies, such as design of experiments and statistical process control, enhance mass transfer and improve process safety. Advancements in microbial growth kinetics and protein folding have led to the development of new media formulations and filtration methods, streamlining the production process. Heat transfer and aeration strategies are essential for maintaining optimal conditions, ensuring stable bioprocesses.
• Chromatography techniques and metabolite analysis provide valuable insights into process performance, enabling continuous process improvement. Innovations in process safety, including oxygen transfer and process control systems, minimize risks and ensure consistent product quality. As the market evolves, the focus on automation and process optimization continues to grow, with automation systems and process modeling becoming increasingly important tools for bioprocess engineers.

Dive into Technavio’s robust research methodology, blending expert interviews, extensive data synthesis, and validated models for unparalleled Bioprocess Technology Market insights. See full methodology.

Request Free Sample

What are the Key Data Covered in this Bioprocess Technology Market Research and Growth Report?

• CAGR of the Bioprocess Technology industry during the forecast period
• Detailed information on factors that will drive the growth and forecasting between 2024 and 2028
• Precise estimation of the size of the market and its contribution of the industry in focus to the parent market
• Accurate predictions about upcoming growth and trends and changes in consumer behaviour
• Growth of the market across North America, Europe, Asia, and Rest of World (ROW)
• Thorough analysis of the market’s competitive landscape and detailed information about companies
• Comprehensive analysis of factors that will challenge the bioprocess technology market growth of industry companies

We can help! Our analysts can customize this bioprocess technology market research report to meet your requirements.

Get in touch